These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27531858)

  • 1. Central cholinergic pathway involvement in the regulation of pupil diameter, blink rate and cognitive function.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Neumann DL; Kavanagh JJ
    Neuroscience; 2016 Oct; 334():180-190. PubMed ID: 27531858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications influencing central cholinergic pathways affect fixation stability, saccadic response time and associated eye movement dynamics during a temporally-cued visual reaction time task.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Modenese L; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Feb; 234(4):671-680. PubMed ID: 27988806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Jan; 234(1):63-71. PubMed ID: 27671681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.
    Kennedy DO; Wake G; Savelev S; Tildesley NT; Perry EK; Wesnes KA; Scholey AB
    Neuropsychopharmacology; 2003 Oct; 28(10):1871-81. PubMed ID: 12888775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective effects of cholinergic modulation on task performance during selective attention.
    Furey ML; Pietrini P; Haxby JV; Drevets WC
    Neuropsychopharmacology; 2008 Mar; 33(4):913-23. PubMed ID: 17534379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition, blinks, eye-movements, and pupillary movements during performance of a running memory task.
    Fukuda K; Stern JA; Brown TB; Russo MB
    Aviat Space Environ Med; 2005 Jul; 76(7 Suppl):C75-85. PubMed ID: 16018333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans.
    Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T
    Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antihistamines with varying anticholinergic properties on voluntary and involuntary movement.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Clin Neurophysiol; 2013 Sep; 124(9):1840-5. PubMed ID: 23643576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic activity in the nervous system: Consequences for visuomotor function.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Physiol Behav; 2017 Mar; 170():6-11. PubMed ID: 27965143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection.
    Wilden J; Rapeport D
    Anaesth Intensive Care; 2004 Jun; 32(3):419-22. PubMed ID: 15264742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.
    Golding JF; Wesnes KA; Leaker BR
    Br J Clin Pharmacol; 2018 Jul; 84(7):1535-1543. PubMed ID: 29522648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dosage promethazine and loratadine negatively affect neuromotor function.
    Kavanagh JJ; Grant GD; Anoopkumar-Dukie S
    Clin Neurophysiol; 2012 Apr; 123(4):780-6. PubMed ID: 21880544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clonidine and scopolamine on multiple target detection in rapid serial visual presentation.
    Brown SB; Slagter HA; van Noorden MS; Giltay EJ; van der Wee NJ; Nieuwenhuis S
    Psychopharmacology (Berl); 2016 Jan; 233(2):341-50. PubMed ID: 26507194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of resource allocation by intelligent individuals in linguistic, mathematical and visuo-spatial tasks.
    Lee G; Ojha A; Kang JS; Lee M
    Int J Psychophysiol; 2015 Jul; 97(1):14-22. PubMed ID: 25931113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic antagonist effects on executive control of attention.
    Thienel R; Kellermann T; Schall U; Voss B; Reske M; Halfter S; Sheldrick AJ; Radenbach K; Habel U; Shah NJ; Kircher T
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1307-17. PubMed ID: 19793402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.
    Danjou P; Molinier P; Berlin I; Patat A; Rosenzweig P; Morselli PL
    Br J Clin Pharmacol; 1992 Oct; 34(4):328-31. PubMed ID: 1360807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
    Low LF; Anstey KJ; Sachdev P
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing peripheral and central cholinergic system responses.
    Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
    J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.
    Liem-Moolenaar M; de Boer P; Timmers M; Schoemaker RC; van Hasselt JG; Schmidt S; van Gerven JM
    Br J Clin Pharmacol; 2011 Jun; 71(6):886-98. PubMed ID: 21306419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD subjects fail to suppress eye blinks and microsaccades while anticipating visual stimuli but recover with medication.
    Fried M; Tsitsiashvili E; Bonneh YS; Sterkin A; Wygnanski-Jaffe T; Epstein T; Polat U
    Vision Res; 2014 Aug; 101():62-72. PubMed ID: 24863585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.